WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. doi: 10.12290/xhyxzz.2021-0678
Citation:
WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. doi: 10.12290/xhyxzz.2021-0678
WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. doi: 10.12290/xhyxzz.2021-0678
Citation:
WANG Yuxin, GUO Xiaoxiao, YANG Deyan, ZHAO Jiuliang, JIANG Ying, HU Rongrong, SHEN Dongchao, MAO Yueying, WANG Lin, YAN Xiaowei. Coronary Aneurysm-like Dilation with Stenosis, Anti-phospholipid Antibody Syndrome, Nephrotic Syndrome, and Polycystic Kidney: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1069-1073. doi: 10.12290/xhyxzz.2021-0678
Department of Pulmonary and Critical Care Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2.
Department of Cardiology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
3.
Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
4.
Department of Nephrology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
5.
Department of Neurology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
6.
Department of Hematopathology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
7.
Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
Funds:
National High Level Hospital Clinical Research Funding2022-PUMCH-A-182
Here we report a case that a young man had early onset myocardial infarction. Coronary angiography showed coronary aneurysm-like dilation and thromboembolism. After stents were implanted, his condition was complicated with repeated stent restenosis. Polycystic kidney, nephrotic syndrome and antiphospholipid antibody syndrome were also present. Antiphospholipid antibody syndrome, a risk factor for recurrent coronary thrombosis, can lead to nephrotic syndrome. Polycystic kidney can be characterized by nephrotic syndrome and may be combined with aneurysmal lesions due to genetic abnormalities. According to the multidisciplinary discussion and follow-up results, the patient was diagnosed as connective tissue diseases and secondary anti-phospholipid antibody syndrome, nephrotic syndrome, and coronary artery lesions. The patient's symptoms improved after treatment for the original disease. The management of this patient broadened our understanding of the etiology of coronary artery disease in young patients and demonstrated the importance of multidisciplinary clinical thinking.
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)[J]. J Thromb Haemost, 2006, 4: 295-306. doi: 10.1111/j.1538-7836.2006.01753.x
[2]
Meroni PL, Raschi E, Testoni C, et al. Antiphospholipid antibodies and the endothelium[J]. Rheum Dis Clin North Am, 2001, 27: 587-602. doi: 10.1016/S0889-857X(05)70222-2
[3]
Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms[J]. J Clin Invest, 2000, 105: 1641-1649. doi: 10.1172/JCI8931
[4]
de Carvalho JF, Shoenfeld Y. Aneurysms in primary antiphospholipid syndrome: a case-based review[J]. Clin Rheumatol, 2021, 40: 3001-3006. doi: 10.1007/s10067-020-05564-9
[5]
Gracia-Tello B, Isenberg D. Kidney disease in primary anti-phospholipid antibody syndrome[J]. Rheumatology, 2017, 56: 1069-1080.
[6]
Bienaimé F, Legendre C, Terzi F, et al. Antiphospholipid syndrome and kidney disease[J]. Kidney Int, 2017, 91: 34-44. doi: 10.1016/j.kint.2016.06.026
[7]
Nochy D, Daugas E, Droz D, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome[J]. J Am Soc Nephrol, 1999, 10: 507-518. doi: 10.1681/ASN.V103507
[8]
Ohara K, Kimura T, Karasawa T, et al. A large coronary aneurysm and its probable precursor lesions in a patient with autosomal dominant polycystic kidney disease: an implication for the process of aneurysmogenesis[J]. Pathol Int, 2012, 62: 758-762. doi: 10.1111/pin.12007
[9]
Neves JB, Rodrigues FB, Lopes JA. Autosomal dominant polycystic kidney disease and coronary artery dissection or aneurysm: a systematic review[J]. Ren Fail, 2016, 38: 493-502. doi: 10.3109/0886022X.2016.1144209
[10]
Visciano B, Di Pietro RA, Rossano R, et al. Nephrotic syndrome and autosomal dominant polycystic kidney disease[J]. Clin Kidney J, 2012, 5: 508-511. doi: 10.1093/ckj/sfs147
[11]
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus[J]. Arthritis Rheumatol, 2019, 71: 1400-1412. doi: 10.1002/art.40930
Submit
Review
Office
Email Alert
RSS
DownLoad: